Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Head and Neck Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 132 articles:
HTML format



Single Articles


    March 2026
  1. HAN JE, Diplas BH, Paudyal R, Oh JH, et al
    Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:1015-1023.
    PubMed     Abstract available


  2. KIM JK, Tam M, Kim SG, Solomon E, et al
    A Phase 2 Exploratory Trial Evaluating Computed Tomography-Based Midtreatment Nodal Response to Select for De-escalated Chemoradiation Therapy in the Definitive Management of p16+ Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:662-675.
    PubMed     Abstract available


  3. CHEN L, Cohen M, Hatzglou V, Zhang Z, et al
    Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).
    Int J Radiat Oncol Biol Phys. 2026;124:676-685.
    PubMed     Abstract available


    February 2026
  4. BENTZEN SM, Gupta T, Jacinto AA, Rosenblatt E, et al
    Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial.
    Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00020.
    PubMed     Abstract available


  5. YANG Y, Jiang Y, Wang C, Li J, et al
    Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial).
    Int J Radiat Oncol Biol Phys. 2026 Feb 17:S0360-3016(26)00390.
    PubMed     Abstract available


  6. CUBERO L, Acosta O, Pascau J, Palard-Novello X, et al
    Voxel-based analysis identifies new functional subregions predictive of xerostomia after head and neck cancer radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 16:S0360-3016(26)00374.
    PubMed     Abstract available


  7. RAAIJMAKERS KTPM, Peters RHW, Beekmans M, Beerkens APM, et al
    Head and Neck Squamous Cell Carcinoma patient-derived Cancer-Associated Fibroblasts undergo senescence while retaining pro-tumorigenic properties after ex vivo irradiation.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00395.
    PubMed     Abstract available


  8. LEHRER EJ, Geyer S, Goodrich A, Haydu LE, et al
    The Impact of Lung and Heart Radiation Dose during Preoperative Chemoradiation on Overall Survival in Esophageal Cancer - A Post Hoc Analysis of CALGB 80803 (Alliance).
    Int J Radiat Oncol Biol Phys. 2026 Feb 5:S0360-3016(26)00362.
    PubMed     Abstract available


  9. GAU M, Su J, Huang SH, Alfaraj FA, et al
    Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis.
    Int J Radiat Oncol Biol Phys. 2026;124:328-339.
    PubMed     Abstract available


  10. SAID BI, Boukhaled GM, Lok BH, Lukovic J, et al
    Cross-Cancer Analysis Reveals a Distinct Pattern of Immune Modulation During Curative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;124:441-450.
    PubMed     Abstract available


  11. CORRY J, Ng WT, Moore A, Choi HCW, et al
    Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low and Middle-Income Countries-Reporting the Technical Component of the Second Phase of a Prospective International Atomic Energy Agency study (E33039).
    Int J Radiat Oncol Biol Phys. 2026;124:311-319.
    PubMed     Abstract available


  12. MCDOWELL L, Corry J, Fua T, Coleman A, et al
    Prospective Evaluation of Patient Priorities in Human Papillomavirus-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design.
    Int J Radiat Oncol Biol Phys. 2026;124:320-327.
    PubMed     Abstract available


    January 2026
  13. SO J, Droznin A, Tiwari P, Chen YH, et al
    Stereotactic Body Radiation Therapy With Pembrolizumab in PD-1 Inhibitor Refractory, Recurrent or Metastatic, Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026 Jan 9:S0360-3016(26)00004.
    PubMed     Abstract available


  14. MILLER ED, Ashman JB, Barry A, Jethwa KR, et al
    Gaining New Ground: The Evolving Role of Radiation Therapy in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Jan 9:S0360-3016(26)00005.
    PubMed     Abstract available


  15. BEDDOK A, Morvan JB, Boudin L, Da Silva Ribeiro Mota A, et al
    The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping Review.
    Int J Radiat Oncol Biol Phys. 2026;124:70-91.
    PubMed     Abstract available


  16. WANG K, Sabouri P, Wolfe A, Siegel E, et al
    Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience.
    Int J Radiat Oncol Biol Phys. 2026;124:147-158.
    PubMed     Abstract available


    December 2025
  17. HUISKES M, Astreinidou E, de Jong M, den Haan N, et al
    Qualitative Blinded Clinical Assessment of Automated and Manual IMPT Plans for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Dec 19:S0360-3016(25)06503.
    PubMed     Abstract available


  18. SASIDHARAN BK, Sidhique SK, Wilson JV, Mathew M, et al
    Pragmatic Patient Choice-Driven Radical Treatment Approach (PRAGRAD) for Very Advanced Unresectable Oral Cavity Cancers.
    Int J Radiat Oncol Biol Phys. 2025;123:1323-1334.
    PubMed     Abstract available


    November 2025
  19. GUAN C, Lu T, Zhan C, Deng S, et al
    Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-label Single-center Randomized Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Nov 29:S0360-3016(25)06536.
    PubMed     Abstract available


  20. LIN Y, Pelkmans J, Epari A, Spikes T, et al
    Associations of Biological Aging with Perceived Stress in Patients with Head and Neck Cancer Undergoing Intensity-Modulated Radiotherapy: A Longitudinal Study.
    Int J Radiat Oncol Biol Phys. 2025 Nov 22:S0360-3016(25)06497.
    PubMed     Abstract available


  21. OBERTOPP N, Bekker RA, Grass GD, Zelenka T, et al
    Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes.
    Int J Radiat Oncol Biol Phys. 2025;123:1102-1115.
    PubMed     Abstract available


  22. GEBRE-MEDHIN M, Adrian G, Engstrom P, Cange HH, et al
    Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.
    Int J Radiat Oncol Biol Phys. 2025;123:681-690.
    PubMed     Abstract available


  23. MOON DH, Avkshtol V, Hughes RS, Ahn C, et al
    HYHOPE: A Phase 1 Study of Deintensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:694-702.
    PubMed     Abstract available


    October 2025
  24. SHAH KD, Chamseddine I, Yuan X, Tian S, et al
    Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets.
    Int J Radiat Oncol Biol Phys. 2025 Oct 11:S0360-3016(25)06336.
    PubMed     Abstract available


  25. TANDON S, Ahlawat P, Mahajan S, Bellige A, et al
    Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025;123:442-451.
    PubMed     Abstract available


    September 2025
  26. CHEN X, Zhang S, Gou X, Dai J, et al
    Tumor Treatment Response Guided Adaptive Dose De-escalation/Escalation Strategy for Concurrent Chemoradiotherapy of Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Sep 26:S0360-3016(25)06314.
    PubMed     Abstract available


  27. FAN C, Lee J, Stock S, Woody NM, et al
    Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:120-128.
    PubMed     Abstract available


    August 2025
  28. ADRIAN G, Falklind NR, McDowell L, Gebre-Medhin M, et al
    Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer Register.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06188.
    PubMed     Abstract available


  29. RUNGE CL, Lyness JA, Gillison ML, Adelstein DJ, et al
    Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx.
    Int J Radiat Oncol Biol Phys. 2025 Aug 17:S0360-3016(25)06157.
    PubMed     Abstract available


    July 2025
  30. LANGER CJ, Harris J, Horwitz EM, Kies M, et al
    Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination with Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): Long-term follow-up of NRG Oncology Radiation Therapy Oncolog
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06032.
    PubMed     Abstract available


  31. RAITANO A, Kilby W, Morrison K, Capo L, et al
    Exploratory rat toxicology and efficacy of the boron neutron capture therapy drug boronotyrosine in a mouse model of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 28:S0360-3016(25)06030.
    PubMed     Abstract available


  32. MAURY P, Sayous Y, Marnaoui R, Loiseau C, et al
    Stereotactic Ablative Radiotherapy (SABR) Quality and Survival of Patients with Head and Neck Cancer: a post-hoc analysis of the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Jul 24:S0360-3016(25)06019.
    PubMed     Abstract available


  33. JAINAR CJE, Jacomina LE, Dee EC, Lee A, et al
    Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04511.
    PubMed     Abstract available


    June 2025
  34. JIANG M, Li H, Chen C, Li Y, et al
    Post-Irradiation Otitis Media with Effusion in Nasopharyngeal Carcinoma: A Comprehensive Review of Pathogenesis, Management, and Prevention.
    Int J Radiat Oncol Biol Phys. 2025 Jun 27:S0360-3016(25)04517.
    PubMed     Abstract available


  35. YILMAZ MT, Cengiz M, Kahvecioglu A, Yigit E, et al
    Fifteen Years of Experience with Stereotactic Body Radiotherapy for Recurrent Head and Neck Cancers: A Detailed Analysis of Patients with Carotid Blowout Syndrome.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04486.
    PubMed     Abstract available


  36. GALLOWAY TJ, Pugh SL, Ridge JA, Nguyen-Tan PF, et al
    Long term feeding tube use in head and neck cancer survivors - a secondary analysis of patient and treatment related factors.
    Int J Radiat Oncol Biol Phys. 2025 Jun 3:S0360-3016(25)00527.
    PubMed     Abstract available


  37. KISER KJ, Apicelli AJ, Brenneman RJ, Contreras JA, et al
    Contralateral Neck Recurrence Rates After Ipsilateral Neck Adjuvant Radiation in Head and Neck Carcinomas with a Pathologically Negative Contralateral Neck.
    Int J Radiat Oncol Biol Phys. 2025 Jun 2:S0360-3016(25)00552.
    PubMed    


  38. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2025;122:355-364.
    PubMed     Abstract available


  39. MORENO AC, Watson EE, Humbert-Vidan L, Peterson DE, et al
    International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study.
    Int J Radiat Oncol Biol Phys. 2025;122:341-354.
    PubMed     Abstract available


  40. FREDERIKS ML, van Etten B, Kelder W, Dieters M, et al
    Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:313-324.
    PubMed     Abstract available


    May 2025
  41. LIN SJ, Guo QJ, Liu Q, Ng WT, et al
    International Consensus Guideline on Delineation of the Clinical Target Volumes (CTV) at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).
    Int J Radiat Oncol Biol Phys. 2025 May 24:S0360-3016(25)00487.
    PubMed     Abstract available


  42. LIU Y, Men Y, Bao Y, Ma Z, et al
    Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data.
    Int J Radiat Oncol Biol Phys. 2025 May 2:S0360-3016(25)00387.
    PubMed     Abstract available


  43. KUIJER KM, Smits HJG, Doornaert PAH, Niu K, et al
    Comparable Performance Between Automatic and Manual Laryngeal and Hypopharyngeal Gross Tumor Volume Delineations Validated With Pathology.
    Int J Radiat Oncol Biol Phys. 2025;122:186-193.
    PubMed     Abstract available


    April 2025
  44. MEHANNA H, Abou-Foul AK, Henson C, Kristunas C, et al
    Accuracy and Prognosis of Extranodal Extension on Radiologic Imaging in Human Papillomavirus-Mediated Oropharyngeal Cancer: a Head and Neck Cancer International Group (HNCIG) real-world study.
    Int J Radiat Oncol Biol Phys. 2025 Apr 24:S0360-3016(25)00370.
    PubMed     Abstract available


  45. HUANG Z, Li Y, Wu W, Wu L, et al
    Plasma Epstein-Barr virus DNA Temporal Clearance Pattern During Induction-concurrent (Chemo)radiotherapy for Risk Stratification in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2025 Apr 7:S0360-3016(25)00349.
    PubMed     Abstract available


  46. MCBRIDE SM
    Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?
    Int J Radiat Oncol Biol Phys. 2025;121:1207-1208.
    PubMed    


    March 2025
  47. SHI JJ, Meduri K, Liao CY, Moon D, et al
    Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.
    Int J Radiat Oncol Biol Phys. 2025 Mar 29:S0360-3016(25)00313.
    PubMed     Abstract available


  48. ENDE TVD, Kuijper SC, Widaatalla Y, Noortman WA, et al
    Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes.
    Int J Radiat Oncol Biol Phys. 2025;121:963-974.
    PubMed     Abstract available


  49. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    PubMed     Abstract available


  50. MORSE RT, Nelson TJ, Liu HC, Sangchan P, et al
    Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.
    Int J Radiat Oncol Biol Phys. 2025;121:684-692.
    PubMed     Abstract available


    February 2025
  51. GARRIDO-HERNANDEZ G, Ytre-Hauge KS, Winter RM, Danielsen S, et al
    In silico interim adaptation of proton therapy in head and neck cancer by simultaneous dose and linear energy transfer escalation.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00154.
    PubMed     Abstract available


  52. YANG L, Liu X, Li Z, Li Z, et al
    Multimodal Image Confidence: A Novel Method for Tumor and Organ Boundary Representation.
    Int J Radiat Oncol Biol Phys. 2025;121:558-569.
    PubMed     Abstract available


  53. SANTOS M, Oliveira E Silva LF, Kohler HF, Curioni O, et al
    Erratum to: Santos M, Oliveira e Silva LF, Kohler HF, et al. Health-Related Quality of Life Outcomes in Head and Neck Cancer: Results From a Prospective, Real-World Data Study With Brazilian Patients Treated With Intensity Modulated Radiation Therapy,
    Int J Radiat Oncol Biol Phys. 2025;121:573.
    PubMed    


    January 2025
  54. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    PubMed     Abstract available


  55. DAMEN PJJ, Peters M, Hobbs B, Chen Y, et al
    Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jan 2:S0360-3016(24)03770.
    PubMed     Abstract available


  56. SANGUINETI G, D'Urso P, Bottero M, Farneti A, et al
    Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2025;121:145-152.
    PubMed     Abstract available


  57. MENG W, Li L, Hao Y, Tang M, et al
    NAD+ Metabolism Reprogramming Mediates Irradiation-Induced Immunosuppressive Polarization of Macrophages.
    Int J Radiat Oncol Biol Phys. 2025;121:176-190.
    PubMed     Abstract available


  58. RAJENDRAN P, Chen Y, Qiu L, Niedermayr T, et al
    Autodelineation of Treatment Target Volume for Radiation Therapy Using Large Language Model-Aided Multimodal Learning.
    Int J Radiat Oncol Biol Phys. 2025;121:230-240.
    PubMed     Abstract available


  59. NG WT, Huang SH, Henson C, Bakst RL, et al
    Looking Forward and Looking Back: Cutting-Edge Advances and Long-Standing Controversies in Head and Neck Cancer Management.
    Int J Radiat Oncol Biol Phys. 2025;121:1-7.
    PubMed    


    December 2024
  60. YANG YX, Yang X, Jiang XB, Lin L, et al
    Artificial Intelligence-Empowered Multistep Integrated Radiation Therapy Workflow for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Dec 19:S0360-3016(24)03670.
    PubMed     Abstract available


  61. GUO R, Zhang WW, Lv JW, Lin JY, et al
    Long-term Outcomes Following Individualized Elective Primary Tumor CTV Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Dec 17:S0360-3016(24)03727.
    PubMed     Abstract available


  62. GUO Q, Huang J, Xiao N, Zhou F, et al
    Long-term outcome in cervical lymph node-positive nasopharyngeal carcinoma following IMRT with one-step cervical nodal CTV delineation by geometric-anatomic expansion from nodal GTV: A double-center experience.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03723.
    PubMed     Abstract available


  63. GRIPPIN A, Kim A, Liu Y, Copling S, et al
    Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies.
    Int J Radiat Oncol Biol Phys. 2024 Dec 12:S0360-3016(24)03724.
    PubMed     Abstract available


  64. RUHLE A
    Stick Your Neck Out: Reirradiate or Not in a Head and Neck Cancer Patient With Extracapsular Extension After Salvage Neck Dissection.
    Int J Radiat Oncol Biol Phys. 2024;120:1205-1206.
    PubMed    


    November 2024
  65. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    PubMed     Abstract available


  66. LUO X, Wang H, Xu J, Li L, et al
    Generalizable MRI-based Nasopharyngeal Carcinoma Delineation: Bridging Gaps across Multiple Centers and Raters with Active Learning.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03644.
    PubMed     Abstract available


  67. WANG L, Wang J, Wang T, Li Y, et al
    The Role of Elective Nodal Irradiation in Treating Clinically Node-Negative Sinonasal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1058-1065.
    PubMed     Abstract available


  68. MCDOWELL L, King MT, Hutcheson KA, Ringash J, et al
    A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials.
    Int J Radiat Oncol Biol Phys. 2024;120:805-822.
    PubMed     Abstract available


  69. ALEXANDER J, Beatty A
    Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients.
    Int J Radiat Oncol Biol Phys. 2024;120:627-638.
    PubMed     Abstract available


  70. VAN RIJN-DEKKER MI, la Bastide-van Gemert S, Stokman MA, Vissink A, et al
    Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    Int J Radiat Oncol Biol Phys. 2024;120:772-782.
    PubMed     Abstract available


    October 2024
  71. ZHANG X, Yan J, Lei Q, Neo J, et al
    A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512.
    PubMed     Abstract available


  72. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    PubMed    


  73. LIAN B, Yang Y, Zheng B, Si L, et al
    Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis.
    Int J Radiat Oncol Biol Phys. 2024;120:528-536.
    PubMed     Abstract available


    September 2024
  74. CAI G, Wang K, Zhao J, Huang B, et al
    Predictive value of changes in basal myocardial (18)F-fluorodeoxyglucose uptake for cardiotoxicity in locally advanced esophageal cancer patients receiving definitive radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Sep 20:S0360-3016(24)03403.
    PubMed     Abstract available


  75. CHARTERS E, Davies S, Sharman AR, Milross C, et al
    Keeping Swallowing on Track During Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:29-32.
    PubMed    


  76. JACOMINA LE, Moreno AC
    Management of Patients With Early-Stage Oropharyngeal Cancer With Clinically Positive Retropharyngeal Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2024;120:13-14.
    PubMed    


  77. WOODY NM
    Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:13.
    PubMed    


    August 2024
  78. CHU H, de Vette SPM, Neh H, Sijtsema NM, et al
    3D deep learning Normal Tissue Complication Probability model to predict late xerostomia in head and neck cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03172.
    PubMed     Abstract available


  79. LIN C, Stevens M
    Mandatory Organ Preservation: Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1334-1335.
    PubMed    


  80. DOU S, Zhu G
    Adenoid Cystic Carcinoma in the Trachea: When Surgery is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2024;119:1333-1334.
    PubMed    


  81. XING TD, Corry J
    A Rare Cancer Arising in an Uncommon Site: Treatment of Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1331-1332.
    PubMed    


  82. HOSSEINIAN S, Hemmati M, Dede C, Salzillo TC, et al
    Cluster-Based Toxicity Estimation of Osteoradionecrosis Via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.
    Int J Radiat Oncol Biol Phys. 2024;119:1569-1578.
    PubMed     Abstract available


  83. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    PubMed     Abstract available


  84. ARISTOPHANOUS M, Aliotta E, Lichtenwalner P, Abraham S, et al
    Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;119:1557-1568.
    PubMed     Abstract available


    July 2024
  85. NORONHA V, Patil V, Menon N, Singh A, et al
    Long term update of a phase 3 randomized study comparing once-a-week versus once-every-3-weeks cisplatin along with radiation in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 27:S0360-3016(24)03139.
    PubMed     Abstract available


  86. SHER DJ, Avkshtol V, Moon D, Vo D, et al
    Stereotactic ablative radiotherapy for T1-2 glottic larynx cancer: mature results from the phase II LT-SABR trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 20:S0360-3016(24)02972.
    PubMed     Abstract available


  87. LI JS, Blanchard P, Wong CHL, Ahn YC, et al
    International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Jul 13:S0360-3016(24)02954.
    PubMed     Abstract available


  88. LI W, Zhao D, Zeng G, Chen Z, et al
    Evaluating Virtual Contrast-enhanced MRI (VCE-MRI) in Nasopharyngeal Carcinoma Radiotherapy: A Retrospective Analysis for Primary Gross Tumor Delineation.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00750.
    PubMed     Abstract available


  89. KATADA C, Yokoyama T, Watanabe A, Hara H, et al
    Optimizing Organ Preservation Strategies through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results from the CROC Multi-Institutional Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00752.
    PubMed     Abstract available


  90. MORSE RT, Mell LK
    Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Int J Radiat Oncol Biol Phys. 2024;119:783-785.
    PubMed    


  91. WILKE C, Henson C, Huang SH, Bakst RL, et al
    Optimizing Therapy: The Art and Science of Modern Head and Neck Radiation.
    Int J Radiat Oncol Biol Phys. 2024;119:709-715.
    PubMed    


  92. LI M, Sun H, Yang W, Luo J, et al
    A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2024;119:896-901.
    PubMed     Abstract available


    June 2024
  93. CHEN B, Chen W, Cheng Q, Zhang H, et al
    Comparison of efficacy and safety of combined chemoimmunotherapy with or without radiotherapy for stage IVB esophageal squamous cell carcinoma: a multicenter propensity score matching analysis.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00741.
    PubMed     Abstract available


  94. ZHANG Z, Zhang J, Zheng R, Ye J, et al
    A Population-Based Tumor-Volume Model for Head-and-Neck Cancer During Radiotherapy with a Dynamic Oxygenated Compartment.
    Int J Radiat Oncol Biol Phys. 2024 Jun 11:S0360-3016(24)00684.
    PubMed     Abstract available


  95. MILGROM SA, van Luijk P, Pino R, Ronckers CM, et al
    Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:467-481.
    PubMed     Abstract available


    May 2024
  96. CHU Y, Zhu C, Hobbs BP, Chen Y, et al
    Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia among Esophageal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00668.
    PubMed     Abstract available


  97. MCVORRAN S, Naghavi A, Schaner P
    Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
    Int J Radiat Oncol Biol Phys. 2024;119:302-303.
    PubMed    


    April 2024
  98. SMITH J, Margalit D, Golledge J, Nastasi D, et al
    Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
    PubMed     Abstract available


  99. HIROSE K, Sato M
    Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
    Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
    PubMed     Abstract available


  100. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
    Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
    Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
    PubMed     Abstract available


  101. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
    Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
    PubMed     Abstract available


    March 2024
  102. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
    An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
    Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
    PubMed     Abstract available


  103. CHEN M, Wang K, Wang J
    Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
    PubMed     Abstract available


  104. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
    Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
    PubMed     Abstract available


  105. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
    PubMed     Abstract available


  106. MOWERY YM
    Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:757-758.
    PubMed    


  107. SAMUELS M, Falkenius J, Bar-Ad V, Dunst J, et al
    A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2024;118:743-756.
    PubMed     Abstract available


  108. ZHANG S, Li K, Sun Y, Wan Y, et al
    Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
    PubMed     Abstract available


    February 2024
  109. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
    Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
    PubMed     Abstract available


  110. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
    Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
    PubMed     Abstract available


  111. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Five-year mortality outcomes for Eating As Treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 4:S0360-3016(24)00248.
    PubMed     Abstract available


  112. GLASER S
    Nodal Recurrence of Uterine Cancer: A Growing Problem.
    Int J Radiat Oncol Biol Phys. 2024;118:319.
    PubMed    


  113. LOUATI S, Wozny AS, Malesys C, Daguenet E, et al
    Differential Formation of Stress Granules in Radiosensitive and Radioresistant Head and Neck Squamous Cell Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2024;118:485-497.
    PubMed     Abstract available


    January 2024
  114. HUISKES M, Kong W, Oud M, Crama K, et al
    Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
    Int J Radiat Oncol Biol Phys. 2024 Jan 27:S0360-3016(23)08308.
    PubMed     Abstract available


  115. HAHN E, Huang SH
    Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;118:179-181.
    PubMed    


  116. LESTER SC, Moon DH, Patel SH, Awan MJ, et al
    Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:165-168.
    PubMed    


  117. XU T, Shen C, Zhou X, Zhu L, et al
    Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IC
    Int J Radiat Oncol Biol Phys. 2024;118:169-178.
    PubMed     Abstract available


  118. MERCADANTE V, Hamad AA, McCaul J, Nutting C, et al
    Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:142-153.
    PubMed     Abstract available


    December 2023
  119. HANNA GJ, Chang SS, Siddiqui F, Bain PA, et al
    Imaging and Biomarker Surveillance for Head and Neck Squamous cell carcinoma: A Systematic Review and Appropriate Use Criteria Document.
    Int J Radiat Oncol Biol Phys. 2023 Dec 31:S0360-3016(23)08258.
    PubMed     Abstract available


  120. DUAN Y, Wang J, Wu P, Chen H, et al
    AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions.
    Int J Radiat Oncol Biol Phys. 2023 Dec 28:S0360-3016(23)08239.
    PubMed     Abstract available


  121. ODHIAMBO DA, Pittman AN, Rickard AG, Castillo RJ, et al
    Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08244.
    PubMed     Abstract available


  122. THOMSON PD, Slevin PN, Baines H, Betts G, et al
    Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184.
    PubMed     Abstract available


  123. KODAIRA T, Kagami Y, Machida R, Shikama N, et al
    Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
    Int J Radiat Oncol Biol Phys. 2023;117:1118-1124.
    PubMed     Abstract available


  124. KYAW JYA, Rendall A, Gillespie EF, Roques T, et al
    Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2023;117:1063-1086.
    PubMed     Abstract available


    November 2023
  125. HAHN E, Ng WT
    Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:925-927.
    PubMed    


  126. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
    Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
    Int J Radiat Oncol Biol Phys. 2023;117:903-913.
    PubMed     Abstract available


  127. RAZAVIAN NB, D'Agostino RB Jr, Shenker RF, Hughes RT, et al
    Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:652-663.
    PubMed     Abstract available


    October 2023
  128. RUHLE A, Weymann M, Behrens M, Marschner S, et al
    A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08025.
    PubMed     Abstract available


  129. RINGASH J, Dunphy C, Avery L, Chahin R, et al
    Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: A phase II randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07957.
    PubMed     Abstract available


  130. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
    Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
    PubMed     Abstract available


  131. MA TM, Wong DJ, Chai-Ho W, Mendelsohn A, et al
    High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:348-354.
    PubMed    


  132. GARDEN AS, Harris J, Eisbruch A, Chao KSC, et al
    Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:333-340.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum